In memory of our Founder, Paul G. Allen
Paul G. Allen, 1953-2018
“Paul’s vision and insight have been an inspiration to me and to many others both here at the Institute that bears his name, and in the myriad of other areas that made up the fantastic universe of his interests. He will be sorely missed. We honor his legacy today, and every day into the long future of the Allen Institute, by carrying out our mission of tackling the hard problems in bioscience and making a significant difference in our respective fields.”
Allan Jones
President and CEO, Allen Institute
News
Annual Report
2018 Annual Report: 15 Years of Impact
November 13, 2018
The Allen Institute was founded in 2003 to tackle hard problems in brain science. This year we're celebrating 15 years since our launch with three divisions, and nearly 500 employees from 34 different scientific disciplines.
Press Release
Research teams from Salk Institute for Biological Studies, Stanford University, University Hospitals Cleveland Medical Center selected to study healthy brain aging, better treatments for neurodegenerative diseases
November 9, 2018
The American Heart Association and Allen Institute announce $43 million commitment in research funding for innovative approaches to combat age-related dementia, including Alzheimer’s disease
News
New Southeast University-Allen Institute collaboration uses VR to capture 3D shapes of mouse neurons
November 1, 2018
Research center headquartered in Nanjing, China, will tackle the thorny problem of reconstructing entire neurons from whole brains
Press Release
A comprehensive 'parts list' of the brain built from its components, the cells
October 31, 2018
In-depth analysis sorts cells from the cerebral cortex into 133 types, lays groundwork to explore function
Press Release
The Paul G. Allen Frontiers Group Announces 10 New Allen Distinguished Investigators
October 30, 2018
$13.5 million awarded to tackle big questions in biology, medical research
News
In memoriam: Allen Institute founder Paul G. Allen
October 15, 2018
We remember our founder, investor and philanthropist Paul G. Allen, and his dedicated work to accelerate bioscience
